Home | NGcGM3/VSSP in patients with metastatic hormone-receptor positive and HER2 negative breast cancer

The revisions let you track differences between multiple versions of a post.

To edit, publish or delete one of the revisions below, click on its saved date.

Published clinical_trials NGcGM3/VSSP in patients with metastatic hormone-receptor positive and HER2 negative breast cancer has 11 revisions.
RevisionStatus
Saved 22/12/2016 - 11:47am by CIM
current revision (published)
Saved 22/12/2016 - 11:46am by CIM
archived
Saved 22/12/2016 - 11:46am by CIM
archived
Saved 22/12/2016 - 11:46am by CIM
archived
Saved 22/12/2016 - 11:46am by CIM
archived
Saved 22/12/2016 - 11:46am by CIM
archived
Saved 22/12/2016 - 11:46am by CIM
archived
Saved 22/12/2016 - 11:45am by CIM
archived
Saved 22/12/2016 - 11:45am by CIM
archived
Saved 22/12/2016 - 11:45am by CIM
archived
Saved 28/11/2016 - 2:33pm by Gladys
archived